A Safety and Effectiveness Study of Immediate Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Acute Non-Cancer Pain

NCT01719601 · clinicaltrials.gov ↗
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The company decided to cancel this study in conformity with PH FDA Circular 2013-004

Conditions

Interventions

Sponsor

Janssen Pharmaceutica